Dr. Mini Bhaskar, MD

Dr. Bhaskar practices at Olmsted Medical Center in Rochester, Minnesota.

Dr. Bhaskar's NPI, 1366453847, was assigned on August 10, 2006. Dr. Bhaskar holds Minnesota license 72802.

Dr. Bhaskar's primary practice is Olmsted Medical Center, at 210 9th SE St, Rochester, MN 55904 in Olmsted County. The practice phone is (507) 288-3443.

Dr. Bhaskar's primary practice is Olmsted Medical Center in Rochester, Minnesota. Dr. Bhaskar is also affiliated with Olmsted Medical Center. The medical group on file is Olmsted Medical Center. Dmand AI also links Dr. Bhaskar to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhaskar practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Bhaskar's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Bhaskar's licenses on file in 3 states: Minnesota, Georgia and Maryland.

CMS data shows 404 Medicare services from Dr. Bhaskar across 5 procedure codes in 2024, for 113 Medicare patients. Medicare paid $23,118 for them. Every service was in an office.

CMS counts 113 Medicare patients who saw Dr. Bhaskar in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have arthritis, and 58% have high blood pressure. 24% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bhaskar's median patient age at 67, with 71% women.

In 2024, Dr. Bhaskar wrote 1,075 Medicare Part D claims for 193 patients. 89% of them were for generic drugs. CMS names the drug for 1,025 of them, across 8 drugs with 11 or more claims each, at $429,783 in total drug cost. In 2023, CMS named 779 claims across 14 drugs.

Dr. Bhaskar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhaskar as offering telehealth.

CMS Open Payments shows 521 general payments to Dr. Bhaskar from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Amgen Inc. paid the most, $1,654.